Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C39H62N10O15S |
Molecular Weight | 943.033 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(O)=O
InChI
InChIKey=AGNIXLPCPQAPSB-SXHLWKDOSA-N
InChI=1S/C39H62N10O15S/c1-16(2)11-25(39(63)64)45-37(61)29(19(5)51)49-35(59)26(14-50)46-38(62)30(20(6)52)48-34(58)24(13-28(41)54)44-36(60)27(15-65)47-32(56)18(4)42-33(57)23(43-31(55)17(3)40)12-21-7-9-22(53)10-8-21/h7-10,16-20,23-27,29-30,50-53,65H,11-15,40H2,1-6H3,(H2,41,54)(H,42,57)(H,43,55)(H,44,60)(H,45,61)(H,46,62)(H,47,56)(H,48,58)(H,49,59)(H,63,64)/t17-,18-,19+,20+,23-,24-,25-,26-,27-,29-,30-/m0/s1
Molecular Formula | C39H62N10O15S |
Molecular Weight | 943.033 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:43:10 GMT 2023
by
admin
on
Sat Dec 16 11:43:10 GMT 2023
|
Record UNII |
PGQ5HC5AMU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10284618
Created by
admin on Sat Dec 16 11:43:10 GMT 2023 , Edited by admin on Sat Dec 16 11:43:10 GMT 2023
|
PRIMARY | |||
|
465500-22-5
Created by
admin on Sat Dec 16 11:43:10 GMT 2023 , Edited by admin on Sat Dec 16 11:43:10 GMT 2023
|
PRIMARY | |||
|
PGQ5HC5AMU
Created by
admin on Sat Dec 16 11:43:10 GMT 2023 , Edited by admin on Sat Dec 16 11:43:10 GMT 2023
|
PRIMARY | |||
|
Survivin
Created by
admin on Sat Dec 16 11:43:10 GMT 2023 , Edited by admin on Sat Dec 16 11:43:10 GMT 2023
|
PRIMARY | The single survivin gene can give rise to four different alternatively spliced transcripts: Survivin-2B, which has an insertion of an alternative exon 2. |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Survivin-2B, a known splice variant of survivin, has been reported to promote cell death in some cancer cells, although it keeps prosurvival function in others, and the mechanisms are unclear. In this report, we discovered that selenite, an antitumor agent, switched protective autophagy to apoptosis in NB4 cells. In this process, the level of survivin-2B was decreased and the interaction between IKK alpha and survivin-2B in the nucleus was attenuated, which further led to the decrease of nuclear IKK alpha. As a result, P73, a known transcript factor of UVRAG, was downregulated. Therefore, the expression of UVRAG, one of the initiators of autophagy, was inhibited. The regulatory status of survivin-2B was also proved in NB4 cells after different chemicals exposure and in other tumor cell lines (Jurkat, HCT116). Finally, experiments in vivo confirmed that the alterations of survivin-2B, IKK alpha, P73 and UVRAG were the same as that in vitro. Taken together, survivin-2B promoted autophagy and further regulated cell death by accumulating and stabilizing IKK alpha in the nucleus.
|